Olejnik-Wojciechowska J, Boboryko D, Bratborska A, Rusinska K, Ostrowski P, Baranowska M
Int J Mol Sci. 2024; 25(7).
PMID: 38612637
PMC: 11011681.
DOI: 10.3390/ijms25073831.
Qi C, Feng F, Guo J, Liu Y, Guo X, Meng Y
J Tradit Complement Med. 2024; 14(1):91-100.
PMID: 38223807
PMC: 10785156.
DOI: 10.1016/j.jtcme.2023.07.005.
West P, Tontini C, Atmoko H, Kiss O, Garner T, Bahri R
Cells. 2023; 12(17).
PMID: 37681909
PMC: 10486964.
DOI: 10.3390/cells12172177.
Sarkhani M, Rostami Mogaddam M, Fattahzadeh-Ardalani G, Fouladi N
An Bras Dermatol. 2023; 98(3):316-323.
PMID: 36681575
PMC: 10173082.
DOI: 10.1016/j.abd.2022.04.009.
Zhang J, Zhao S, Xing X, Shang L, Cao J, He Y
J Inflamm Res. 2023; 16:35-43.
PMID: 36636251
PMC: 9831526.
DOI: 10.2147/JIR.S397079.
How Does Botulinum Toxin Inhibit Itch?.
Gazerani P
Toxins (Basel). 2022; 14(10).
PMID: 36287970
PMC: 9610088.
DOI: 10.3390/toxins14100701.
Immunologic aspects of migraine: A review of literature.
Salahi M, Parsa S, Nourmohammadi D, Razmkhah Z, Salimi O, Rahmani M
Front Neurol. 2022; 13:944791.
PMID: 36247795
PMC: 9554313.
DOI: 10.3389/fneur.2022.944791.
The Role of Interleukins in the Pathogenesis of Dermatological Immune-Mediated Diseases.
Turchin I, Bourcier M
Adv Ther. 2022; 39(10):4474-4508.
PMID: 35997892
PMC: 9395905.
DOI: 10.1007/s12325-022-02241-y.
Botulinum Toxin Use for Modulating Neuroimmune Cutaneous Activity in Psoriasis.
Popescu M, Beiu C, Iliescu M, Mihai M, Popa L, Stanescu A
Medicina (Kaunas). 2022; 58(6).
PMID: 35744076
PMC: 9228985.
DOI: 10.3390/medicina58060813.
The Trinity of Skin: Skin Homeostasis as a Neuro-Endocrine-Immune Organ.
Jin R, Luo L, Zheng J
Life (Basel). 2022; 12(5).
PMID: 35629392
PMC: 9144330.
DOI: 10.3390/life12050725.
Pruritus: A Sensory Symptom Generated in Cutaneous Immuno-Neuronal Crosstalk.
Szollosi A, Olah A, Lisztes E, Griger Z, Toth B
Front Pharmacol. 2022; 13:745658.
PMID: 35321329
PMC: 8937025.
DOI: 10.3389/fphar.2022.745658.
Sleep Disorders and Psoriasis: An Update.
Halioua B, Chelli C, Misery L, Taieb J, Taieb C
Acta Derm Venereol. 2022; 102:adv00699.
PMID: 35191513
PMC: 9574693.
DOI: 10.2340/actadv.v102.1991.
Topical Treatment of Colquhounia Root Relieves Skin Inflammation and Itch in Imiquimod-Induced Psoriasiform Dermatitis in Mice.
Li F, Han D, Wang B, Zhang W, Zhao Y, Xu J
Mediators Inflamm. 2022; 2022:5782922.
PMID: 35069008
PMC: 8767412.
DOI: 10.1155/2022/5782922.
Transcriptional Analysis-Based Alterations Affecting Neuritogenesis of the Peripheral Nervous System in Psoriasis.
Romhanyi D, Szabo K, Kemeny L, Sebestyen E, Groma G
Life (Basel). 2022; 12(1).
PMID: 35054504
PMC: 8778302.
DOI: 10.3390/life12010111.
Peripheral Mechanisms of Itch.
Guo C, Grabinski N, Liu Q
J Invest Dermatol. 2021; 142(1):31-41.
PMID: 34838258
PMC: 9134748.
DOI: 10.1016/j.jid.2021.10.024.
Maximizing the Utility of Transcriptomics Data in Inflammatory Skin Diseases.
Wu J, Fang Z, Liu T, Hu W, Wu Y, Li S
Front Immunol. 2021; 12:761890.
PMID: 34777377
PMC: 8586455.
DOI: 10.3389/fimmu.2021.761890.
Roles of calcitonin gene-related peptide in the skin, and other physiological and pathophysiological functions.
Kim Y, Granstein R
Brain Behav Immun Health. 2021; 18:100361.
PMID: 34746878
PMC: 8551410.
DOI: 10.1016/j.bbih.2021.100361.
Characteristics of Pruritus according to Morphological Phenotype of Psoriasis and Association with Neuropeptides and Interleukin-31.
Park S, Kim G, Kim H, Ko H, Kim M, Kim B
Ann Dermatol. 2021; 32(1):1-7.
PMID: 33911702
PMC: 7992637.
DOI: 10.5021/ad.2020.32.1.1.
Pruritus in psoriasis and atopic dermatitis: current treatments and new perspectives.
Kahremany S, Hofmann L, Harari M, Gruzman A, Cohen G
Pharmacol Rep. 2021; 73(2):443-453.
PMID: 33460006
DOI: 10.1007/s43440-020-00206-y.
Autoimmunity in Segmental Vitiligo.
Speeckaert R, Lambert J, Bulat V, Belpaire A, Speeckaert M, van Geel N
Front Immunol. 2020; 11:568447.
PMID: 33193342
PMC: 7655129.
DOI: 10.3389/fimmu.2020.568447.